Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2015

01.10.2015 | Epidemiology

Breast cancer screening utilization and understanding of current guidelines among rural U.S. women with private insurance

verfasst von: Jeffrey Peppercorn, Kevin Houck, Nina Beri, Victor Villagra, Adane F. Wogu, Gary H. Lyman, Stephanie B. Wheeler

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Women living in rural areas of the U.S. face disparities in screening mammography and breast cancer outcomes. We sought to evaluate utilization of mammography, awareness of screening guidelines, and attitudes towards screening among rural insured U.S. women. We conducted a cross-sectional self-administered anonymous survey among 2000 women aged 40–64 insured by the National Rural Electric Cooperative Association, a non-profit insurer for electrical utility workers in predominantly rural areas across the U.S. Outcomes included mammographic screening in the past year, screening interval, awareness of guidelines, and perceived barriers to screening. 1588 women responded to the survey (response rate 79.4 %). 74 % of respondents lived in a rural area. Among women aged 40–49, 66.5 % reported mammographic screening in the past year. 46 % received annual screening, 32 % biennial screening, and 22 % rare/no screening. Among women aged 50–64, 77.1 % reported screening in the past year. 63 % received annual screening, 25 % biennial screening, and 12 % rare/no screening. The majority of women (98 %) believed that the mammography can find breast cancer early and save lives. Less than 1 % of younger women, and only 14 % of women over age 50 identified the recommendations of the U.S. Preventative Services Screening Task Force as the current expert recommendations for screening. Screening practices tended to follow perceived guideline recommendations. When rural U.S. women over age 40 have insurance, most receive breast cancer screening. The screening guidelines of cancer advocacy groups and specialty societies appear more influential and widely recognized than those of the U.S. preventative services taskforce.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Beverage JN, Sissung TM, Sion AM, Danesi R, Figg WD (2007) CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci 96(9):2224–2231CrossRefPubMed Beverage JN, Sissung TM, Sion AM, Danesi R, Figg WD (2007) CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci 96(9):2224–2231CrossRefPubMed
2.
Zurück zum Zitat Donahue SR, Flockhart DA, Abernethy DR, Ko JW (1997) Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19. Clin Pharmacol Ther 62(5):572–577CrossRefPubMed Donahue SR, Flockhart DA, Abernethy DR, Ko JW (1997) Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19. Clin Pharmacol Ther 62(5):572–577CrossRefPubMed
3.
Zurück zum Zitat Dowsett M, Goldhirsch A, Hayes DF, Senn HJ, Wood W, Viale G (2007) International Web-based consultation on priorities for translational breast cancer research. Breast Cancer Res 9(6):R81PubMedCentralCrossRefPubMed Dowsett M, Goldhirsch A, Hayes DF, Senn HJ, Wood W, Viale G (2007) International Web-based consultation on priorities for translational breast cancer research. Breast Cancer Res 9(6):R81PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E et al (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 19(Suppl 1):14–25CrossRefPubMed Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E et al (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 19(Suppl 1):14–25CrossRefPubMed
5.
Zurück zum Zitat Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J et al (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663CrossRefPubMed Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J et al (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663CrossRefPubMed
6.
Zurück zum Zitat Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R (2014) Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst 106(11) Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R (2014) Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst 106(11)
7.
Zurück zum Zitat Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA (2001) Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91(9):1724–1731CrossRefPubMed Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA (2001) Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91(9):1724–1731CrossRefPubMed
8.
Zurück zum Zitat Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C et al (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95(3):458–469CrossRefPubMed Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C et al (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95(3):458–469CrossRefPubMed
9.
Zurück zum Zitat Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ, National Evaluation Team for Breast Cancer S (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361(9367):1411–1417CrossRefPubMed Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ, National Evaluation Team for Breast Cancer S (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361(9367):1411–1417CrossRefPubMed
10.
Zurück zum Zitat Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP (2005) Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR Am J Roentgenol 184(1):324–329CrossRefPubMed Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP (2005) Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR Am J Roentgenol 184(1):324–329CrossRefPubMed
11.
Zurück zum Zitat Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366PubMedCentralCrossRefPubMed Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working G (2015) Breast-cancer screening–viewpoint of the IARC Working Group. N Engl J Med 372(24):2353–2358CrossRefPubMed Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working G (2015) Breast-cancer screening–viewpoint of the IARC Working Group. N Engl J Med 372(24):2353–2358CrossRefPubMed
13.
Zurück zum Zitat EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717CrossRef EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717CrossRef
14.
Zurück zum Zitat Eisinger F (2008) CYP2D6 and Ockham’s razor. J Clin Oncol 26(4):686–687 (author reply 687) CrossRefPubMed Eisinger F (2008) CYP2D6 and Ockham’s razor. J Clin Oncol 26(4):686–687 (author reply 687) CrossRefPubMed
15.
Zurück zum Zitat Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737PubMedCentralCrossRefPubMed Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Partridge AH, Winer EP (2009) On mammography–more agreement than disagreement. N Engl J Med 361(26):2499–2501CrossRefPubMed Partridge AH, Winer EP (2009) On mammography–more agreement than disagreement. N Engl J Med 361(26):2499–2501CrossRefPubMed
17.
Zurück zum Zitat Kopans DB (2015) An open letter to panels that are deciding guidelines for breast cancer screening. Breast Cancer Res Treat 151(1):19–25CrossRefPubMed Kopans DB (2015) An open letter to panels that are deciding guidelines for breast cancer screening. Breast Cancer Res Treat 151(1):19–25CrossRefPubMed
18.
Zurück zum Zitat Purc-Stephenson RJ, Gorey KM (2008) Lower adherence to screening mammography guidelines among ethnic minority women in America: a meta-analytic review. Prev Med 46(6):479–488PubMedCentralCrossRefPubMed Purc-Stephenson RJ, Gorey KM (2008) Lower adherence to screening mammography guidelines among ethnic minority women in America: a meta-analytic review. Prev Med 46(6):479–488PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Onitilo AA, Engel JM, Liang H, Stankowski RV, Miskowiak DA, Broton M (2013) Doi SA Mammography utilization: patient characteristics and breast cancer stage at diagnosis. AJR Am J Roentgenol 201(5):1057–1063CrossRefPubMed Onitilo AA, Engel JM, Liang H, Stankowski RV, Miskowiak DA, Broton M (2013) Doi SA Mammography utilization: patient characteristics and breast cancer stage at diagnosis. AJR Am J Roentgenol 201(5):1057–1063CrossRefPubMed
20.
Zurück zum Zitat Paskett ED, Tatum C, Rushing J, Michielutte R, Bell R, Foley KL, Bittoni M, Dickinson S (2004) Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population. Cancer 101(11):2650–2659PubMedCentralCrossRefPubMed Paskett ED, Tatum C, Rushing J, Michielutte R, Bell R, Foley KL, Bittoni M, Dickinson S (2004) Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population. Cancer 101(11):2650–2659PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Nguyen-Pham S, Leung J, McLaughlin D (2014) Disparities in breast cancer stage at diagnosis in urban and rural adult women: a systematic review and meta-analysis. Ann Epidemiol 24(3):228–235CrossRefPubMed Nguyen-Pham S, Leung J, McLaughlin D (2014) Disparities in breast cancer stage at diagnosis in urban and rural adult women: a systematic review and meta-analysis. Ann Epidemiol 24(3):228–235CrossRefPubMed
22.
Zurück zum Zitat Singh GK, Williams SD, Siahpush M, Mulhollen A (2011) Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part ii-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol 2011:107497PubMedCentralCrossRefPubMed Singh GK, Williams SD, Siahpush M, Mulhollen A (2011) Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part ii-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol 2011:107497PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Meissner HI, Klabunde CN, Breen N, Zapka JM (2012) Breast and colorectal cancer screening: U.S. primary care physicians’ reports of barriers. Am J Prev Med 43(6):584–589CrossRefPubMed Meissner HI, Klabunde CN, Breen N, Zapka JM (2012) Breast and colorectal cancer screening: U.S. primary care physicians’ reports of barriers. Am J Prev Med 43(6):584–589CrossRefPubMed
24.
Zurück zum Zitat Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM (2014) Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology 270(2):354–361PubMedCentralCrossRefPubMed Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM (2014) Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology 270(2):354–361PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119(14):2518–2523CrossRefPubMed Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119(14):2518–2523CrossRefPubMed
27.
Zurück zum Zitat Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM (2014) Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. N C Med J 75(4):239–246PubMed Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM (2014) Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. N C Med J 75(4):239–246PubMed
28.
Zurück zum Zitat Feldstein AC, Perrin N, Rosales AG, Schneider J, Rix MM, Keels K, Schoap S, Glasgow RE (2009) Effect of a multimodal reminder program on repeat mammogram screening. Am J Prev Med 37(2):94–101PubMedCentralCrossRefPubMed Feldstein AC, Perrin N, Rosales AG, Schneider J, Rix MM, Keels K, Schoap S, Glasgow RE (2009) Effect of a multimodal reminder program on repeat mammogram screening. Am J Prev Med 37(2):94–101PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat Hegenscheid K, Hoffmann W, Fochler S, Domin M, Weiss S, Hartmann B, Bick U, Hosten N (2011) Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial. Am J Prev Med 41(4):421–427CrossRefPubMed Hegenscheid K, Hoffmann W, Fochler S, Domin M, Weiss S, Hartmann B, Bick U, Hosten N (2011) Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial. Am J Prev Med 41(4):421–427CrossRefPubMed
30.
Zurück zum Zitat Kelaher M, Cawson J, Miller J, Kavanagh A, Dunt D, Studdert DM (2008) Use of breast cancer screening and treatment services by Australian women aged 25–44 years following Kylie Minogue’s breast cancer diagnosis. Int J Epidemiol 37(6):1326–1332CrossRefPubMed Kelaher M, Cawson J, Miller J, Kavanagh A, Dunt D, Studdert DM (2008) Use of breast cancer screening and treatment services by Australian women aged 25–44 years following Kylie Minogue’s breast cancer diagnosis. Int J Epidemiol 37(6):1326–1332CrossRefPubMed
Metadaten
Titel
Breast cancer screening utilization and understanding of current guidelines among rural U.S. women with private insurance
verfasst von
Jeffrey Peppercorn
Kevin Houck
Nina Beri
Victor Villagra
Adane F. Wogu
Gary H. Lyman
Stephanie B. Wheeler
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2015
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3566-1

Weitere Artikel der Ausgabe 3/2015

Breast Cancer Research and Treatment 3/2015 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.